Vaxart ( (VXRT)) has shared an announcement. On July 6, 2026, Vaxart reported 12-month topline safety data from the approximately 400-participant sentinel safety cohort of its Phase 2b trial comparing ...

Vaxart ( (VXRT)) just unveiled an announcement. On July 16, 2026, Vaxart held its annual meeting of stockholders in a virtual-only format, with a quorum representing about 45.7% of outstanding shares.

Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 17.8% to $0.66 Tuesday morning amid a number of recent news items. The company recently secured a contract from the U.S. Government via the ...

Those who chased its prior rallies may have ended up with losses. But as shares make another retreat, this may be a vaccine play worth rolling the dice on. Emphasis on “rolling the dice.” This company ...

Investors should simply avoid Vaxart (NASDAQ:VXRT) stock at this time. Although VXRT stock has an interesting business model, there is arguably not much behind it. I’ll get to that in a moment, but ...